Arden Bio
Arden Bio is an Even One Ventures company outside cancer: it profiles the immune system of people with complex immune-mediated conditions to match them to biology-based treatments.
Overview
Arden Bio, led by chief executive Bala Raja, offers people with complex immune-mediated conditions a case assessment built on advanced immune profiling, which its site says analyses more than 10,000 molecular data points to help their physicians identify the mechanisms driving the condition and personalise treatment. It is one of the immunology companies in the Even One Ventures portfolio and is not working on cancer; it is recorded here because the fund's whole portfolio is tracked.
Funding
All startupsSimilar pages
not linked directly; found by shared links- CompanyIgnitus Bio
Shares Even One Ventures and the tags startup, evenone-portfolio, non-oncology.
- CompanyPerita Bio
Shares Even One Ventures and the tags startup, evenone-portfolio, non-oncology.
- CompanyRarivive
Shares Even One Ventures and the tags startup, evenone-portfolio, non-oncology.
- CompanyRelit Biosciences
Shares Even One Ventures and the tags startup, evenone-portfolio.
- CompanyEcho Immune
Shares Even One Ventures and the tags startup, evenone-portfolio.
- CompanyRanata Therapeutics
Shares Even One Ventures and the tags startup, evenone-portfolio.
- CompanyStitchpoint Bio
Shares Even One Ventures and the tags startup, evenone-portfolio, non-oncology.
- CompanyYuga Bio
Shares Even One Ventures and the tags startup, evenone-portfolio.